Community/Retail

Teens prescribed anti-anxiety or sleep medications may be up to 12 times more likely to abuse those drugs illegally than teens who have never received a prescription, often by obtaining additional pills from friends or family members.

Amgen has discontinued its studies on rilotumumab in advanced gastric cancer after an increased number of deaths were reported among patients receiving rilotumumab and chemotherapy, compared with those only undergoing chemotherapy.

Digoxin is associated with a 71% increased risk of death and a 63% higher risk of hospitalization among adults diagnosed with atrial fibrillation who have no evidence of heart failure.

B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association, discusses new adherence programs independent pharmacists are using.

Megan E. Saunders, PharmD, details the challenges she has encountered in pharmacy school.

Vince Canzanese, RPh, director of compounding at Burmans Pharmacy discusses some of the hot topics at the Brookhaven, Pennsylvania independent pharmacy.

A study from Bristol-Myers Squibb shows a combination of abatacept and methotrexate could help slow the disease progression of rheumatoid arthritis.

Two Rite Aid employees in Moultrie, Georgia, have been accused of stealing prescription medications from their own pharmacy, according to the Moultrie Observer.

No more missed doses with innovative pill bottle.

Networking is one of the most important aspects to ensure your success in pharmacy.

Patients with bipolar disorder who are treated with lithium have a higher risk for long-lasting kidney damage and thus require rigorous monitoring.

Clinical practice guidelines for the diagnosis and treatment of certain types of cancer are surprisingly unstandardized.

Baxter International, Inc, is voluntarily recalling 1 lot of its highly concentrated potassium chloride injection due to mislabeling.

Vitamin D deficiencies are causally associated with increased mortality rates.

Johnson & Johnson announced today a global partnership with Save the Children that has the potential to help millions of children over the next three years.

The FDA has granted orphan drug designation to a treatment for a rare disease that primarily affects kidney function.

Improved patient access to medications and fewer patent expirations will result in a 30% increase in global drug spending, to $1.3 trillion, over the next 5 years.

Two new analyses of more than 60,000 patients found dabigatran etexilate was linked to fewer major bleeds and strokes than warfarin.

A former pharmacy technician thought the prescription pill records she was finagling were better shred than read.

A Maryland pharmacist has been charged with the theft of more than 7300 tablets of hydrocodone, a painkiller found in Vicodin and Lortab.

Expanding upon efforts to implement the federal Drug Quality and Security Act enacted 1 year ago, the FDA today released 3 policy documents that assist companies that compound sterile drugs with registering as outsourcing facilities.

Based on patient response rates and efficacy, olanzapine/fluoxetine is the ideal first-line treatment for depression caused by bipolar disorder.

Bayer is expanding its aid donations for Ebola patients in Liberia and Sierra Leone.

Forever Beautiful Bee Pollen and Forever Beautiful Infinity were found to be forever dangerous to consumers.

Several provisions of the Affordable Care Act intend to improve smoking cessation rates by increasing insurance coverage for effective interventions.

During cold and flu season, working women turn to pharmacies whenever symptoms appear, according to the results of a recent study conducted by Workplace Impact.

Sanofi and Regeneron Pharmaceutics, Inc, have convinced the FDA that their atopic dermatitis treatment works well enough to undergo accelerated development and regulatory review.